Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy (Q44487535)

3 December 2017

title

Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy (English)

1 reference

3 December 2017

5

Roger F Butterworth

1 reference

3 December 2017

3

Nicolas Chatauret

1 reference

3 December 2017

Samir Ahboucha

1

1 reference

3 December 2017

Paul Desjardins

series ordinal

2

1 reference

3 December 2017

Gilles Pomier-Layrargues

series ordinal

4

1 reference

3 December 2017

publication date

1 November 2003

1 reference

Neurochemistry International

3 December 2017

published in

1 reference

3 December 2017

volume

43

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

551-556

1 reference

Supersensitivity of Benzodiazepine Receptors in Hepatic Encephalopathy Due to Fulminant Hepatic Failure in the Rat: Reversal by a Benzodiazepine Antagonist

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

The astrocytic ("peripheral-type") benzodiazepine receptor: role in the pathogenesis of portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein mRNA in brain following portacaval anastomosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Increased densities of binding sites for the 'peripheral-type' benzodiazepine receptor ligand [3H]PK 11195 in rat brain following portacaval anastomosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Improvement of hepatic encephalopathy treated with flumazenil

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Hepatic encephalopathy: An update of pathophysiologic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Increased densities of peripheral-type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Regional Distribution and Kinetics of Three Sites on the GABAA Receptor: Lack of Effect of Portacaval Shunting

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

An update on GABAA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Plasma and CSF benzodiazepine receptor ligand concentrations in cirrhotic patients with hepatic encephalopathy: relationship to severity of encephalopathy and to pharmaceutical benzodiazepine intake

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

Cerebral uptake of benzodiazepine measured by positron emission tomography in hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2803%2900065-2

7 January 2021

10.1016/S0197-0186(03)00065-2

Identifiers

DOI

1 reference

3 December 2017

1 reference